(CercleFinance.com) – As part of its strategic evolution focused on the development of new processes favoring in particular the development of biotherapies, Hybrigenics announces the appointment of Léone Atayi to the general management of the company.
Léone Atayi has worked for more than ten years in the field of biotechnology and the pharmaceutical industry. She notably held the position of administrative and financial director within a world leader in transfection reagents.
‘Its contribution and a favorable market have enabled the company to multiply its turnover tenfold in four years and increase its valuation, which rose from 10 to 500 million euros upon the sale of this company’, Hybrigenics emphasizes.
Copyright © 2022 CercleFinance.com. All rights reserved.
Did you like this article ? Share it with your friends with the buttons below.
